$6.51
17.18% today
Nasdaq, Apr 04, 09:44 pm CET
ISIN
US23306J1016
Symbol
DBVT
Sector
Industry

DBV Technologies SA Sponsored ADR Stock price

$7.86
+3.90 98.48% 1M
+4.46 131.18% 6M
+4.77 154.37% YTD
+0.36 4.80% 1Y
-8.94 53.21% 3Y
-29.54 78.98% 5Y
-239.04 96.82% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
+0.16 2.08%
ISIN
US23306J1016
Symbol
DBVT
Sector
Industry

Key metrics

Market capitalization $161.21m
P/E (TTM) P/E ratio negative
P/B ratio (TTM) P/B ratio 2.80
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-120.24m
Cash position $32.50m
EPS (TTM) EPS $-5.85
P/S forward 80.61
Short interest 0.33%

Is DBV Technologies SA Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

DBV Technologies SA Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a DBV Technologies SA Sponsored ADR forecast:

3x Buy
100%

Analyst Opinions

3 Analysts have issued a DBV Technologies SA Sponsored ADR forecast:

Buy
100%

Financial data from DBV Technologies SA Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
- -
-
100%
- Direct Costs 12 12
361% 361%
-
- -
-
-
- Selling and Administrative Expenses 25 25
8% 8%
-
- Research and Development Expense 83 83
13% 13%
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -120 -120
30% 30%
-
Net Profit -114 -114
57% 57%
-

In millions USD.

Don't miss a Thing! We will send you all news about DBV Technologies SA Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

DBV Technologies SA Sponsored ADR Stock News

Positive
Market Watch
7 days ago
American depositary receipts of DBV Technologies gained after the company reported new financing of up to $306.9 million.
Neutral
GlobeNewsWire
8 days ago
Châtillon, France, March 27, 2025 DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved DBV secures $125.5 million (€116.3 million) up front and up to $181.4 million (€168.2 million), subject to the full exercise of warrants DBV sufficiently funded th...
Neutral
GlobeNewsWire
12 days ago
Châtillon, France, March 24, 2025 DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for Biologics License Application (BLA) for Viaskin® Peanut Patch in 4 – 7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, and Reports 2024 Unaudited Financial Results 1 COMFORT Children supplemental safety study in children 4 – 7-years-old no longer requir...
More DBV Technologies SA Sponsored ADR News

Company Profile

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. It focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Montrouge, France.

Head office France
CEO Daniel Tassé
Founded 2002
Website www.dbv-technologies.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today